Literature DB >> 2897430

Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence.

J R Sanchez-Ramos1, P Michel, W J Weiner, F Hefti.   

Abstract

Dopaminergic neurons in cultures of dissociated cells from fetal rat mesencephalon were exposed to the principal metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenyl-pyridinium ion (MPP+), and several of its structural analogues. At concentrations between 0.01 and 0.1 microM, MPP+ inhibited catecholamine accumulation as visualized by cytofluorescence. Between 0.1 and 10.0 microM, MPP+ resulted in disappearance of tyrosine hydroxylase immunoreactivity without affecting other cells in the cultures. At concentrations higher than 10 microM, MPP+ was toxic to all cells present in the cultures. The effect of low concentrations of MPP+ on catecholamine cytofluorescence of the dopaminergic neurons was partially reversible. The intermediate concentrations produced irreversible structural changes of tyrosine hydroxylase-positive cells, resulting in complete disappearance of these neurons. The morphological changes were specific to the dopaminergic neurons and were not evident in other cells viewed with phase contrast microscopy. Of the structural analogues tested, the 1-ethyl analogue of MPP+ was effective in selectively destroying dopaminergic neurons in our culture system. The antioxidants L-acetyl-carnitine, beta-carotene, and alpha-tocopherol failed to protect against MPP+ neurotoxicity when co-incubated with the toxin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897430     DOI: 10.1111/j.1471-4159.1988.tb02500.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Topological and chronological features of the impairment of glucose metabolism induced by 1-methyl-4-phenylpyridinium ion (MPP+) in rat brain slices.

Authors:  N Maruoka; T Murata; N Omata; Y Takashima; Y Fujibayashi; Y Wada
Journal:  J Neural Transm (Vienna)       Date:  2007-04-16       Impact factor: 3.575

2.  Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.

Authors:  M S Sutphin; T D Buckman
Journal:  Neurochem Res       Date:  1991-12       Impact factor: 3.996

3.  Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration.

Authors:  P T Bywood; S M Johnson
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

4.  Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

Authors:  Matthew Benskey; Ki Yong Lee; Kevin Parikh; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2013-05-01       Impact factor: 4.294

5.  Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).

Authors:  E Koutsilieri; W W Chan; D Reinitzer; W D Rausch
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology.

Authors:  Jinhong Wie; Zhenjiang Liu; Haikun Song; Thomas F Tropea; Lu Yang; Huanhuan Wang; Yuling Liang; Chunlei Cang; Kimberly Aranda; Joey Lohmann; Jing Yang; Boxun Lu; Alice S Chen-Plotkin; Kelvin C Luk; Dejian Ren
Journal:  Nature       Date:  2021-01-27       Impact factor: 49.962

7.  Aerobic exercise improves motor function and striatal MSNs-Erk/MAPK signaling in mice with 6-OHDA-induced Parkinson's disease.

Authors:  Xiaodong Wang; Yinhao Wang; Jian Chen; Juan Li; Yang Liu; Wei Chen
Journal:  Exp Brain Res       Date:  2022-04-06       Impact factor: 1.972

Review 8.  Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease.

Authors:  Lijuan Hou; Wei Chen; Xiaoli Liu; Decai Qiao; Fu-Ming Zhou
Journal:  Front Aging Neurosci       Date:  2017-11-03       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.